PRIORITIES FOR DEVELOPING A MORTALITY RISK PREDICTION TOOL FOR PEOPLE WITH KIDNEY FAILURE: AN END-USER CONSENSUS WORKSHOP

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/88aa1090f9d3e8d02214787266cb2237.pdf
PRIORITIES FOR DEVELOPING A MORTALITY RISK PREDICTION TOOL FOR PEOPLE WITH KIDNEY FAILURE: AN END-USER CONSENSUS WORKSHOP

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Ping
Liu
Ping Liu ping.liu1@ucalgary.ca University of Calgary Department of Medicine, Department of Community Health Sciences Calgary Canada *
Niamh Caffrey niamh.caffrey@ucalgary.ca University of Calgary Department of Medicine, Department of Oncology Calgary Canada -
Maoliosa Donald donaldm@ucalgary.ca University of Calgary Department of Medicine, Department of Community Health Sciences Calgary Canada -
Michelle Smekal msmekal@ucalgary.ca University of Calgary Department of Medicine Calgary Canada -
Meghan Harris meghan.harris@ucalgary.ca University of Calgary Department of Community Health Sciences Calgary Canada -
Helen Tam-Tham tamh@ucalgary.ca University of Calgary Department of Oncology, Department of Family Medicine Calgary Canada -
D'Arcy Duquette dvcjduquette@shaw.ca University of Calgary Patient Partner, Nephrology Research Group Calgary Canada -
Amit Garg Amit.Garg@lhsc.on.ca Western University Department of Medicine, Department of Epidemiology & Biostatistics London Canada -
Gregory Hundemer ghundemer@toh.ca University of Ottawa, Ottawa Hospital Research Institute Department of Medicine, Inflammation and Chronic Disease Program Ottawa Canada -
Christian Fynbo Christiansen cfc@clin.au.dk Aarhus University Department of Clinical Epidemiology, Department of Clinical Medicine Aarhhus Denmark -
Simon Sawhney simon.sawhney@abdn.ac.uk University of Aberdeen Aberdeen Centre for Health Data Science Aberdeen United Kingdom -
Pietro Ravani pravani@ucalgary.ca University of Calgary Department of Medicine, Department of Community Health Sciences Calgary Canada -
Meghan Elliott mjelliot@ucalgary.ca University of Calgary Department of Medicine, Department of Community Health Sciences Calgary Canada -